Ensoma Focuses on Key Gene Therapy

Ensoma, a biotech company in Boston, is making big changes. The company decided to let go of more employees. This follows earlier job cuts in November.

Ensoma will now focus on its most important drug. This drug is a gene therapy for a rare immune system disease. To do this, the company will pause other early-stage research. This helps Ensoma save money and put all its efforts into one promising treatment.

The company believes this new plan will help it succeed. They want to bring their lead gene therapy to patients who need it. This move shows how biotech companies must make tough choices to develop new medicines.

Source: FierceBiotech